Track symptoms, medications,
Keep record of your ongoing condition and symptoms, schedule your medication reminders, or keep track of your sleep and steps.
Propel yourself with health insights and AI-enabled learning
Learn from AI-enabled personal insights that are generated based on correlations in your symptoms, mood, and treatment activities.
Best Mobile Apps, 2018 Muse Creative Awards Platinum Winner
chemoWave is your virtual advocate through cancer,
helping you do everything in your power to feel better.
In the news
chemoWave has been featured as a game-changing app for patients and a valuable tool in health care by top publications like CNBC, FOX News, CURE, NY Post, AJMC, FOX Business, MedScape, and many others.
million new cancer cases in the US every year
of the top 25 cancer hospitals represented by chemoWave users
types of cancer in our chemoWave community
a cancer app that helps you take control
Manage your symptoms & condition
Keep track of your overall wellbeing and learn how to better understand how your experiences are related to feeling better or worse.
See personal health insights
Record your treatment journey and see customized, relevant insights that help empower you with actionable information — propel yourself with your own data.
Share updates with your care team
Email or print out reports of your symptoms, condition, and activities to better manage your time with doctors and care providers. Make better decisions together with your team.
Meet our team
Creator & CEO
User Engagement / Creative Director
Software Engineer / Technical Lead
Still wondering what chemoWave can do?
check out this 30 second app preview
chemoWave is developed & managed by Treatment Technologies & Insights Inc., a global digital health company that creates patient-centered mobile apps, along with physician portals and research databases. Tapping into the power of patient reported outcomes (PROs), TTI’s technology is focused on capturing and operationalizing PROs to impact healthcare. Starting first in oncology, TTI plans to deploy its technology across multiple chronic disease states that could benefit from increased patient involvement and monitoring.